Imre
Executive Summary
Carl Pinksy, MD, chief medical officer of the National Cancer Institute's biological response modifier program, to VP-medical affairs. Pinsky assisted in the design of the firm's first clinical trial of its Prosorba column in 1983, when he was with Memorial Sloan-Kettering.